Picture of Atara Biotherapeutics logo

ATRA Atara Biotherapeutics Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMid CapMomentum Trap

Annual cashflow statement for Atara Biotherapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

R2017
December 31st
2018
December 31st
2019
December 31st
2020
December 31st
2021
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-119-231-291-307-340
Depreciation
Non-Cash Items23.832.252.453.857.7
Unusual Items
Other Non-Cash Items
Changes in Working Capital7.215-4.1563.752.6
Change in Accounts Receivable
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Other Liabilities
Cash from Operating Activities-87.5-180-236-181-221
Capital Expenditures-20.2-35.9-5.73-4.51-10.6
Purchase of Fixed Assets
Other Investing Cash Flow Items120-16066.2-11632.8
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Cash from Investing Activities99.9-19660.5-12122.3
Financing Cash Flow Items0.89217.20.6554.995.5
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities20358189428104
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash32.5-18.513.6126-94.3

Or unlock with your email

Or unlock with your email